P Martinez-Martin

Summary

Publications

  1. ncbi Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease
    P Martinez-Martin
    Unidad de Investigacion, Centro Alzheimer Fundación Reina Sofía y CIBERNED, Instituto de Salud Carlos III, Madrid, España Electronic address
    Neurologia 29:153-60. 2014
  2. doi Is AD a homogeneous nosologic entity? Yes
    P Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    J Neural Transm 120:1467-73. 2013
  3. doi Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis
    P Martinez-Martin
    Alzheimer Center Reina Sofia Foundation and Consortium for Biomedical Research in Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain
    Eur J Neurol 20:1198-203. 2013
  4. doi Instruments for holistic assessment of Parkinson's disease
    Pablo Martinez-Martin
    Research Unit, Alzheimer Center Reina Sofia Foundation, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neural Transm 120:559-64. 2013
  5. doi Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
    Pablo Martinez-Martin
    AD Research Unit, Alzheimer Center Reina Sofia Foundation and CIBERNED, Carlos III Institute of Health, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neurol 260:228-36. 2013
  6. doi A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neurol 259:2299-308. 2012
  7. doi A rating scale for gait evaluation in cognitive deterioration (RSGE-CD): validation study
    Pablo Martinez-Martin
    Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    J Alzheimers Dis 31:543-53. 2012
  8. doi Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
    Pablo Martinez-Martin
    Research Unit, Alzheimer Center Reina Sofia Foundation, and CIBERNED Carlos III Institute of Health, C Valderrebollo, 5, 28031 Madrid, Spain
    J Neurol 259:1639-47. 2012
  9. doi The Q10 questionnaire for detection of wearing-off phenomena in Parkinson's disease
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    Parkinsonism Relat Disord 18:382-5. 2012
  10. doi Quality of life and burden in caregivers for patients with Parkinson's disease: concepts, assessment and related factors
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Cl Valderrebollo, 5, 28031 Madrid, Spain
    Expert Rev Pharmacoecon Outcomes Res 12:221-30. 2012

Detail Information

Publications28

  1. ncbi Factors determining when to start levodopa/carbidopa/entacapone treatment in Spanish patients with Parkinson's disease
    P Martinez-Martin
    Unidad de Investigacion, Centro Alzheimer Fundación Reina Sofía y CIBERNED, Instituto de Salud Carlos III, Madrid, España Electronic address
    Neurologia 29:153-60. 2014
    ..Several therapeutic options are available for the symptomatic treatment of Parkinson's disease (PD).There is no reliable information about which factors are involved in the choice of treatment...
  2. doi Is AD a homogeneous nosologic entity? Yes
    P Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    J Neural Transm 120:1467-73. 2013
    ..Hopefully, scientific advances (in genetics, proteomics, metabolomics, etc.) will allow a more precise definition of the disease in the future...
  3. doi Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis
    P Martinez-Martin
    Alzheimer Center Reina Sofia Foundation and Consortium for Biomedical Research in Neurodegenerative Diseases, Carlos III Institute of Health, Madrid, Spain
    Eur J Neurol 20:1198-203. 2013
    ..The objective of the present cross-sectional, international study was to identify shared elements and grouping of components from anxiety scales as a basis for designing a new scale for use in PD...
  4. doi Instruments for holistic assessment of Parkinson's disease
    Pablo Martinez-Martin
    Research Unit, Alzheimer Center Reina Sofia Foundation, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neural Transm 120:559-64. 2013
    ..This article shows a pragmatic review of common instruments (rating scales and questionnaires) usable for a comprehensive assessment of PD and provides information about sources for guiding the selection of measures and outcome analyses...
  5. doi Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
    Pablo Martinez-Martin
    AD Research Unit, Alzheimer Center Reina Sofia Foundation and CIBERNED, Carlos III Institute of Health, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neurol 260:228-36. 2013
    ..Results confirm those of the original study and add information on scale reliability, construct validity, and precision. The MDS-UPDRS Spanish version shows satisfactory clinimetric characteristics...
  6. doi A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, C Valderrebollo, 5, 28031, Madrid, Spain
    J Neurol 259:2299-308. 2012
    ..The precision of the scale dimensions was acceptable. The SEND-PD performed as an acceptable, consistent, valid, and precise scale for evaluation of neuropsychiatric symptoms in Parkinson's disease...
  7. doi A rating scale for gait evaluation in cognitive deterioration (RSGE-CD): validation study
    Pablo Martinez-Martin
    Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    J Alzheimers Dis 31:543-53. 2012
    ..0001). The RSGE-CD showed low standard errors of measurement. In this first validation study, the RSGE-CD showed satisfactory clinimetric attributes for assessing gait and mobility across the complete range of cognitive state...
  8. doi Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
    Pablo Martinez-Martin
    Research Unit, Alzheimer Center Reina Sofia Foundation, and CIBERNED Carlos III Institute of Health, C Valderrebollo, 5, 28031 Madrid, Spain
    J Neurol 259:1639-47. 2012
    ..Gender-related patterns of NMS involvement may be relevant for clinical trials in PD...
  9. doi The Q10 questionnaire for detection of wearing-off phenomena in Parkinson's disease
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    Parkinsonism Relat Disord 18:382-5. 2012
    ..62-0.64). Comparison with the QUICK and WOQ-9 shows that the Q10 can be a new tool for detection of wearing-off with satisfactory properties and a good balance between brevity and performance...
  10. doi Quality of life and burden in caregivers for patients with Parkinson's disease: concepts, assessment and related factors
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation Reina Sofia Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Cl Valderrebollo, 5, 28031 Madrid, Spain
    Expert Rev Pharmacoecon Outcomes Res 12:221-30. 2012
    ..The implementation of effective interventions to preserve the caregiver's wellbeing and allow the patients to remain at home and be properly assisted is a pragmatic consequence of this knowledge...
  11. doi The importance of non-motor disturbances to quality of life in Parkinson's disease
    Pablo Martinez-Martin
    Alzheimer Disease Research Unit, Alzheimer Center Reina Sofia Foundation, and CIBERNED, Carlos III Institute of Health, Madrid, Spain
    J Neurol Sci 310:12-6. 2011
    ..In that scenario, the whole NMS showed a close association with the quality of life deterioration, exceeding even the effects of the motor disorder...
  12. ncbi [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study]
    P Martinez-Martin
    Unidad de Investigación del Proyecto Alzheimer, Fundación Cien Fundación Reina Sofía, Madrid, Espana
    Rev Neurol 49:393-8. 2009
    ..To perform an independent evaluation of the psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS)...
  13. doi Assessing autonomic symptoms of Parkinson's disease with the SCOPA-AUT: a new perspective from Rasch analysis
    M J Forjaz
    National School of Public Health and Consortium for Biomedical Research in Neurodegenerative Diseases, Madrid, Spain
    Eur J Neurol 17:273-9. 2010
    ..This study sought to test whether the SCOPA-AUT meets item response theory standards for reliability, internal construct validity, response category ordering, and differential item functioning by gender and age group...
  14. doi Should the SCOPA-COG be modified? A Rasch analysis perspective
    M J Forjaz
    National School of Public Health and CIBERNED, Carlos III Institute of Health, Madrid, Spain
    Eur J Neurol 17:202-7. 2010
    ..This study aims at analysing the SCOPA-COG according to the Rasch model and, on the basis of results, suggesting modification to the SCOPA-COG...
  15. doi Psychometric properties of the International Wellbeing Index in community-dwelling older adults
    C Rodriguez-Blazquez
    National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain
    Int Psychogeriatr 23:161-9. 2011
    ..This is the first study to analyze the psychometric properties of the International Wellbeing Index (IWI), which comprises the Personal Wellbeing Index (PWI) and National Wellbeing Index (NWI), among community-dwelling older adults...
  16. ncbi [The current state of the art concerning quality of life in Parkinson's disease: II. Determining and associated factors]
    M J Forjaz
    Escuela Nacional de Sanidad, Instituto de Salud Carlos III, E 28029 Madrid, Espana
    Rev Neurol 49:655-60. 2009
    ..AIM. This paper is the second part of a review of the current state of the art concerning HRQL in PD and focuses on its main determining and associated factors...
  17. doi Independent validation of the scales for outcomes in Parkinson's disease-autonomic (SCOPA-AUT)
    C Rodriguez-Blazquez
    Area of Applied Epidemiology, National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain
    Eur J Neurol 17:194-201. 2010
    ..This study is the first independent validation of the Scales for Outcomes in PD-Autonomic (SCOPA-AUT)...
  18. ncbi [The current state of the art concerning quality of life in Parkinson's disease: I. Instruments, comparative studies and treatments]
    B Frades-Payo
    Area de Epidemiología Aplicada y CIBERNED, Sección de Neuroepidemiología, Instituto de Salud Carlos III, 28029 Madrid, Espana
    Rev Neurol 49:594-8. 2009
    ..This review is part of a series of two papers, the aim of which is to describe the current situation of studies on HRQL in PD and to detect areas in which knowledge is lacking, as a possible guide to researchers in future projects...
  19. ncbi [A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep]
    P Martinez-Martin
    Sección de Neuroepidemiología, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, 28029 Madrid, Spain
    Rev Neurol 43:577-83. 2006
    ....
  20. ncbi [Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver]
    P Martinez-Martin
    Area de Epidemiología Aplicada, Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain
    Rev Neurol 39:639-45. 2004
    ..Moreover, the information about their impact on the quality of life of caregivers (QLC) is scarce...
  21. doi Psychometric properties of the Spanish QoL-AD with institutionalized dementia patients and their family caregivers in Spain
    B León-Salas
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    Aging Ment Health 15:775-83. 2011
    ..To evaluate the psychometric attributes of the Spanish version of the Quality of Life-Alzheimer's Disease Scale (QoL-AD) in institutionalized patients and family caregivers in Spain...
  22. ncbi [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review]
    P Martinez-Martin
    Centro Nacional de Epidemiologia, CIBERNED e Instituto de Salud Carlos III, Madrid, Espana
    Rev Neurol 49:1-7. 2009
    ..To evaluate the psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS) in Spain and to compare them with previous studies...
  23. doi Dementia associated with Parkinson's disease: applying the Movement Disorder Society Task Force criteria
    P Martinez-Martin
    Alzheimer Disease Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid, Spain
    Parkinsonism Relat Disord 17:621-4. 2011
    ..The objective of this study was to explore the utility of the new MDS-TF criteria and procedures in clinical practice...
  24. doi International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease
    P Martinez-Martin
    National Center of Epidemiology, Carlos III Institute of Health, Av Monforte de Lemos, 3, 28029 Madrid, Spain
    Neurology 73:1584-91. 2009
    ..The Non-Motor Symptoms Scale (NMSS) is an instrument specifically designed for the comprehensive assessment of NMS in patients with PD. NMSS psychometric properties have been tested in this study...
  25. ncbi Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS)
    J Benito-Leon
    Department of Neurology, Mostoles General Hospital, and Gregorio Marañón University, Madrid, Spain
    Mult Scler 13:645-51. 2007
    ..The Fatigue Impact Scale for Daily Use (D-FIS) is an eight-item instrument designed to measure subjective daily experience of fatigue. This study sought to determine the metric properties of the D-FIS in multiple sclerosis (MS) patients...
  26. doi [Factors associated with dementia caregivers' preference for institutional care]
    J Lopez
    Universidad San Pablo CEU, Boadilla del Monte, Madrid, Espana
    Neurologia 27:83-9. 2012
    ..The purpose of this study is to identify which variables are associated with caregivers' desire for institutionalization their dementia relatives...
  27. doi Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain
    J Virues-Ortega
    National Centre for Epidemiology, Research Network in Nerodegenerative Disease, Carlos III Institute of Health, Madrid, Spain
    Acta Neurol Scand 123:316-24. 2011
    ..To estimate dementia prevalence in Spain...
  28. doi Relationship between the MDS-UPDRS domains and the health-related quality of life of Parkinson's disease patients
    P Martinez-Martin
    Alzheimer Center Reina Sofia Foundation and CIBERNED, Carlos III Institute of Health, Madrid, Spain
    Eur J Neurol 21:519-24. 2014
    ..The present study was aimed at determining the relationships between MDS-UPDRS components and health-related quality of life (HRQoL) evaluations in PD patients...